Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,744.00
Bid: 4,744.00
Ask: 4,748.00
Change: -146.00 (-2.99%)
Spread: 4.00 (0.084%)
Open: 4,884.00
High: 4,884.00
Low: 4,716.00
Prev. Close: 4,890.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

6 Apr 2010 07:00

RNS Number : 6831J
Intertek Group PLC
06 April 2010
 



6 April 2010

 

Intertek makes acquisition from BASF

 

Intertek Group plc (Intertek), the leading international provider of quality and safety services to a wide range of industries, announces that it has acquired for cash the Regulatory and Safety Testing businesses of Ciba Expert Services (Ciba ES) from BASF SE.

 

The gross assets acquired are approximately GBP 4 million and the revenue that the business will generate is expected to be around GBP 20 million in the first year.

 

Ciba ES provides services in two segments: regulatory testing and consulting services; and environmental and safety testing, to companies in industries including pharmaceutical, chemical, food, healthcare, consumer product and agriculture. The business employs around 200 people across Switzerland, Canada, UK, China, India, Brazil, Italy and Japan and offers a range of services and expertise complementary to Intertek Group's services and clients.

 

Ciba ES' Regulatory Services help clients to gain health, safety and environmental approvals for their products and to address hazardous substances and chemicals notifications and regulations worldwide, such as the EU's 'REACH' chemicals registration regime and various regulations in the US and China. The businesses have particular expertise in supporting products being launched in highly regulated markets, such as healthcare, nutrition and chemicals, where more stringent legislation applies. CIBA ES' Safety Testing services are used by a range of global companies primarily in the pharmaceutical and chemicals sectors to ensure their products meet relevant safety requirements.

 

The businesses will form part of Intertek's Industrial Services and Analytical Services divisions.

 

 

 

Contacts

Aston Swift / Sarah Ogilvie Intertek

Telephone: +44 (0) 20 7396 3400

aston.swift@intertek.com / sarah.ogilvie@intertek.com

 

 

Richard Mountain / Sophie Kernon, Financial Dynamics

Telephone: +44 (0) 20 7269 7121

richard.mountain@fd.com / sophie.kernon@fd.com

 

 

Notes to Editors

ABOUT INTERTEK

Intertek is a leading provider of quality and safety solutions serving a wide range of industries around the world. From auditing and inspection, to testing, quality assurance and certification, Intertek people are dedicated to adding value to customers' products and processes, supporting their success in the global marketplace. Intertek has the expertise, resources and global reach to support its customers through its network of more than 1,000 laboratories and offices and over 25,000 people in more than 100 countries around the world.

Intertek Group plc (LSE: ITRK) is listed on the London Stock Exchange and is a constituent of the FTSE 100 index.

 

www.intertek.com

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEASLFEDLEEFF
Date   Source Headline
1st Sep 20151:00 pmRNSTotal Voting Rights
3rd Aug 20151:00 pmRNSTotal Voting Rights
3rd Aug 20157:00 amRNSHalf Yearly Report
27th Jul 20153:00 pmRNSHolding(s) in Company
1st Jul 20151:00 pmRNSTotal Voting Rights
23rd Jun 20157:00 amRNSDirectorate Change
1st Jun 20151:00 pmRNSTotal Voting Rights
21st May 20154:01 pmRNSBlocklisting Interim Review
21st May 20154:01 pmRNSBlocklisting Interim Review
21st May 20154:00 pmRNSDirector/PDMR Shareholding
15th May 20154:15 pmRNSDirectorate Change
15th May 20154:15 pmRNSResult of AGM
15th May 20157:00 amRNSAGM Trading Update
1st May 20151:00 pmRNSTotal Voting Rights
21st Apr 20159:00 amRNSDirector Declaration
13th Apr 20157:00 amRNSAnnual Financial Report
1st Apr 20151:00 pmRNSTotal Voting Rights
9th Mar 20153:50 pmRNSDirector/PDMR Shareholding
9th Mar 20153:50 pmRNSDirector/PDMR Shareholding
9th Mar 20153:50 pmRNSDirector/PDMR Shareholding
4th Mar 20152:00 pmRNSHolding(s) in Company
2nd Mar 20151:00 pmRNSTotal Voting Rights
2nd Mar 20157:00 amRNSFinal Results
2nd Feb 20151:00 pmRNSTotal Voting Rights
2nd Jan 20151:00 pmRNSTotal Voting Rights
19th Dec 20143:26 pmRNSDirector Declaration
18th Dec 20142:00 pmRNSDirector/PDMR Shareholding
15th Dec 20143:00 pmRNSHolding(s) in Company
12th Dec 20142:00 pmRNSHolding(s) in Company
8th Dec 20142:00 pmRNSHolding(s) in Company
4th Dec 20142:00 pmRNSHolding(s) in Company
1st Dec 20141:00 pmRNSTotal Voting Rights
26th Nov 20142:00 pmRNSHolding(s) in Company
21st Nov 20141:00 pmRNSBlocklisting Interim Review
21st Nov 20141:00 pmRNSBlocklisting Interim Review
19th Nov 20147:00 amRNSInterim Management Statement
3rd Nov 20141:00 pmRNSTotal Voting Rights
14th Oct 20142:00 pmRNSHolding(s) in Company
13th Oct 20142:00 pmRNSHolding(s) in Company
6th Oct 20142:00 pmRNSHolding(s) in Company
3rd Oct 20142:00 pmRNSHolding(s) in Company
3rd Oct 20142:00 pmRNSHolding(s) in Company
1st Oct 20141:00 pmRNSTotal Voting Rights
30th Sep 20147:00 amRNSDirectorate Change
1st Sep 20141:00 pmRNSTotal Voting Rights
18th Aug 20144:30 pmRNSHolding(s) in Company
4th Aug 20147:00 amRNSHalf Yearly Report
1st Aug 20141:00 pmRNSTotal Voting Rights
1st Jul 20141:00 pmRNSTotal Voting Rights
6th Jun 20144:00 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.